Brett Hagen Biography and Net Worth

CAO of AlloVir

Brett R. Hagen is the Chief Accounting Officer at AlloVir.

What is Brett R. Hagen's net worth?: The estimated net worth of Brett R. Hagen is at least $17,344.25 as of March 26th, 2025. Mr. Hagen owns 1,925 shares of AlloVir stock worth more than $17,344 as of March 28th. This net worth approximation does not reflect any other assets that Mr. Hagen may own. Learn More about Brett R. Hagen's net worth.
How old is Brett R. Hagen?: Mr. Hagen is currently 51 years old. There are 7 older executives and no younger executives at AlloVir. The oldest executive at AlloVir is Mr. Vikas Sinha C.A., CPA, M.B.A., President, CFO & Director, who is 61 years old. Learn More on Brett R. Hagen's age.
How do I contact Brett R. Hagen?: The corporate mailing address for Mr. Hagen and other AlloVir executives is 139 MAIN STREET SUITE 500, CAMBRIDGE MA, 02142. AlloVir can also be reached via phone at 617-433-2605 and via email at ir@allovir.com. Learn More on Brett R. Hagen's contact information.
Has Brett R. Hagen been buying or selling shares of AlloVir?: During the past quarter, Brett R. Hagen has sold $8,619.83 in shares of AlloVir stock. Most recently, Brett R. Hagen sold 907 shares of the business's stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of $8.97, for a transaction totalling $8,135.79. Following the completion of the sale, the chief accounting officer now directly owns 1,925 shares of the company's stock, valued at $17,267.25. Learn More on Brett R. Hagen's trading history.
Who are AlloVir's active insiders?: AlloVir's insider roster includes Ercem Atillasoy (Insider), Jeffrey Bornstein (Director), Brett Hagen (CAO), David Hallal (Director), Morana Jovan-Embiricos (Director), Ann Leen (Insider), Agustin Melian (Insider), Jeroen Van Beek (Insider), Juan Vera (Director), and John Wilson (Director). Learn More on AlloVir's active insiders.
Are insiders buying or selling shares of AlloVir?: In the last year, insiders at the sold shares 47 times. They sold a total of 5,878 shares worth more than $90,414.75. The most recent insider tranaction occured on March, 26th when CAO Brett R Hagen sold 907 shares worth more than $8,135.79. Insiders at AlloVir own 32.1% of the company. Learn More about insider trades at AlloVir.
Information on this page was last updated on 3/26/2025.

Brett R. Hagen Insider Trading History at AlloVir

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/26/2025	Sell	907	$8.97	$8,135.79	1,925
1/23/2025	Sell	36	$9.51	$342.36	2,928
1/10/2025	Sell	14	$10.12	$141.68	2,964
11/19/2024	Sell	24	$12.65	$303.60	2,978
10/21/2024	Sell	20	$17.94	$358.80	3,095
10/3/2024	Sell	13	$18.63	$242.19	3,116
8/5/2024	Sell	73	$16.79	$1,225.67	3,153
7/22/2024	Sell	20	$17.02	$340.40	3,226
7/19/2024	Sell	20	$17.25	$345.00	3,247
5/3/2024	Sell	69	$18.40	$1,269.60	3,305
4/22/2024	Sell	20	$17.25	$345.00	3,374
4/19/2024	Sell	20	$17.25	$345.00	3,395
4/2/2024	Sell	12	$17.71	$212.52	3,416
2/8/2024	Sell	484	$15.41	$7,458.44	3,449
2/5/2024	Sell	251	$15.41	$3,867.91	3,934
1/23/2024	Sell	39	$15.41	$600.99	4,186
1/4/2024	Sell	13	$14.72	$191.36	4,225
11/17/2023	Sell	17	$37.49	$637.33	5,471
10/19/2023	Sell	15	$36.34	$545.10	5,504
10/3/2023	Sell	9	$45.54	$409.86	5,519
8/17/2023	Sell	71	$57.50	$4,082.50	5,529
7/19/2023	Sell	14	$81.88	$1,146.32	5,616
6/9/2023	Sell	219	$129.72	$28,408.68	5,630
4/19/2023	Sell	15	$85.33	$1,279.95	5,865
1/19/2023	Sell	67	$116.84	$7,828.28	3,232
11/10/2022	Sell	260	$184.00	$47,840.00	4,083
10/24/2022	Sell	86	$186.99	$16,081.14	4,343
10/21/2022	Sell	492	$194.35	$95,620.20	4,430
10/19/2022	Sell	15	$215.28	$3,229.20	4,923
4/20/2022	Sell	12	$153.64	$1,843.68	3,494
1/20/2022	Sell	67	$201.25	$13,483.75
2/22/2021	Sell	34	$992.22	$33,735.48	2,815
2/17/2021	Sell	100	$929.66	$92,966.00	2,996

See Full Table

Brett R. Hagen Buying and Selling Activity at AlloVir

AlloVir Company Overview

AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.

Today's Range

Now: $9.01

$9.01

$9.91

50 Day Range

MA: $9.82

$8.82

$11.47

2 Week Range

Now: $9.01

$7.96

$24.15

Volume

18,903 shs

Average Volume

16,674 shs

Market Capitalization

$45.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Brett Hagen Biography and Net Worth

What is Brett R. Hagen's net worth?

How old is Brett R. Hagen?

How do I contact Brett R. Hagen?

Has Brett R. Hagen been buying or selling shares of AlloVir?

Who are AlloVir's active insiders?

Are insiders buying or selling shares of AlloVir?